<SEC-DOCUMENT>0001193125-19-055585-index.html : 20190228 <SEC-HEADER>0001193125-19-055585.hdr.sgml : 20190228 <ACCEPTANCE-DATETIME>20190228073826 ACCESSION NUMBER: 0001193125-19-055585 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 EFFECTIVENESS DATE: 20190228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-229934 FILM NUMBER: 19640477 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 </SEC-HEADER> <DOCUMENT> <TYPE>S-3ASR <SEQUENCE>1 <FILENAME>d702076ds3asr.htm <DESCRIPTION>S-3ASR <TEXT> Document 1 - file: d702076ds3asr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d702076dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d702076dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>d702076dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: d702076dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g702076g0226191154946.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g702076g0226191154946.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g702076g97p26.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g702076g97p26.jpg
</DOCUMENT> </SEC-DOCUMENT>